Please use this identifier to cite or link to this item: http://localhost:80/xmlui/handle/123456789/1604
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHayat, Khizar-
dc.contributor.authorKhurshid, A-
dc.contributor.authorRafiq, M A-
dc.contributor.authorDurrani, S K-
dc.contributor.authorZaidi, S S Z-
dc.contributor.authorM Ikram, M-
dc.date.accessioned2019-11-20T10:48:47Z-
dc.date.available2019-11-20T10:48:47Z-
dc.date.issued2013-01-01-
dc.identifier.issn10 025603-
dc.identifier.urihttp://142.54.178.187:9060/xmlui/handle/123456789/1604-
dc.description.abstractNanoparticles are extensively used as efficient drug carriers in various biological studies. PEGylated barium manganate powder consisting of nanoparticles was synthesized using a hydrothermal technique. The nanoparticle morphology of the powder was confirmed via scanning electron microscopy. The average diameter of the nanoparticles was ~90 nm. The x-ray diffraction pattern revealed that these nanoparticles consisted of single phase polycrystalline 2H-BaMnO3. The PEGylated BaMnO3 nanoparticles were loaded with 5-aminolevulinic acid (5-ALA) to evaluate their drug carrying potential. The toxicity of these nanoparticles was tested against the Hep2c cell line and found to be suitable for biological applications. It was seen that the drug uptake was a million times higher in the case of encapsulation compared to a conventional drug delivery system. This new formulation may find extensive use in nanomedicine as a multidrug delivery system.en_US
dc.language.isoen_USen_US
dc.publisherInstitute of Physicsen_US
dc.subjectNatural Scienceen_US
dc.subjectBaMnO3en_US
dc.subjectdelivery agentsen_US
dc.titleThe potential of PEGylated BaMnO3 nanoparticles as drug delivery agentsen_US
dc.typeArticleen_US
Appears in Collections:Journals

Files in This Item:
File Description SizeFormat 
pdf.htm139 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.